GI
GILD icon

GAMMA Investing’s Gilead Sciences GILD Stock Holding History

GAMMA Investing’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.39M Buy
34,746
+598
+2% +$78.8K 0.16% 92
2026
Q1 		$4.76M Buy
34,148
+3,193
+10% +$447K 0.22% 69
2025
Q4 		$3.8M Buy
30,955
+3,537
+13% +$430K 0.19% 76
2025
Q3 		$3.04M Buy
27,418
+1,799
+7% +$204K 0.17% 91
2025
Q2 		$2.84M Buy
25,619
+2,859
+13% +$304K 0.18% 87
2025
Q1 		$2.55M Buy
22,760
+4,532
+25% +$468K 0.19% 88
2024
Q4 		$1.68M Buy
18,228
+2,955
+19% +$266K 0.14% 123
2024
Q3 		$1.28M Buy
15,273
+5,333
+54% +$407K 0.13% 152
2024
Q2 		$682K Buy
9,940
+3,567
+56% +$238K 0.09% 197
2024
Q1 		$467K Sell
6,373
-336
-5% -$25.8K 0.1% 198
2023
Q4 		$525K Buy
+6,709
New +$522K 0.14% 120

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

GAMMA Investing's GILD Position: Q2 2026 in Review

GAMMA Investing increased its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, buying an estimated $78.8K and bringing the position to 34,746 shares worth $4.39M. The position accounts for 0.16% of the portfolio, ranked #92.

GAMMA Investing first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.76M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • GAMMA Investing held 34,746 shares of Gilead Sciences worth $4.39M as of Q2 2026.
  • GAMMA Investing bought 598 Gilead Sciences shares in Q2 2026, an estimated $78.8K.
  • Gilead Sciences made up 0.16% of GAMMA Investing's portfolio in Q2 2026, its #92 holding.
  • GAMMA Investing first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Gilead Sciences position peaked at $4.76M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.